Company profile
High Sierra Technologies, Inc.
OTC: HSTI · Healthcare · Drug Manufacturers - Specialty & Generic
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ 47GM —SS 46
v0.1 · 25/100 weight · pillars only
↑ disclosure history, listing tenure · ↓ Altman-Z, workforce scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$324.0k
Employees
3
as of 2026-08-20
Market cap
$29.3M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02020
Net income-$324.0k-$324.0k2022
Operating income-$238.4k-$238.4k2022
Total assets$101.5k$101.5k2022
Liabilities$611.8k$611.8k2022
Equity-$510.3k-$510.3k2022
Revenue trend
FY2013 – FY2020 · USD
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is High Sierra Technologies, Inc.’s revenue?
High Sierra Technologies, Inc. booked $0 in FY2020 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Grace Therapeutics, Inc.48DNanoViricides, Inc.35DLite Strategy, Inc.49DBeyondSpring Inc.34DSona Nanotech Inc.——Defence Therapeutics Inc.——Neighbors
Washoe →Key facts
CEOVincent C. Lombardi
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersReno, NV
ExchangeOTC: HSTI
Employees3
IPO date2007-09-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.